Epstein Secrets

Purchase 3131/19 Percentage Unrealized Asset Description Yield Date Quantity Cost Value of Total Gain (Loss) FIXED INCOME JP Morgan Chase & Co Pfd 7.9% April 30 2049 7.900% 6/15/11 5.760.000 6.244.622 5.788.800 17.58% -455.822 Goldman Sachs 5.375% Fixed to 5-10-2020 then 392.2 over 3 m 5

078 3.106.900 2.67% 93.822 SX7E Market Plus Note - Eurpean Bank Index Exp 41202019172% barrier) 10/24/17 3,000,000 2,086,290 1.80% -913.710 United Technologies UTX 6/21/18 15,000 1,882.944 1,933.350 1.66% 50,406 Amazon AMZN 4/2/18 1.000 1.395.441 1.780.750 1.53% 385.309 Allergan AGN 3/13/19

Purchase 9/30/18 3/31119 Asset Description Yield Date Quantity Cost Value Value Difference FIXED INCOME JP Morgan Chase & Co Pfd 7.9% April 30 2049 7.900% 6/15/11 5,760,000 6,244,622 5,842,294 5,788,800 -53,494 Goldman Sachs 5.375% Fixed to 5-10-2020 then 392.2 oval 5.3

0 3,013,078 3.106,900 93,822 SX7E Market Plus Note- Eurpean Bank Index Exp 0202019 ( 2% barn 10/24/17 3,000.000 2,562,150 2,086.290 -475,860 United Technologies UTX 6/21/18 15.000 1.882.944 2.097.150 1.933.350 -163.800 Amazon AMZN 4/2/18 1,000 1,395.441 2.003.000 1.780,750 -222,250 Allergan

schneider Group Inc. USA Dilenschneider Philip Dilley Chairman Arup Group Ltd United Kingdom James Dimon Chairman and Chief Executive Officer JPMorgan Chase 8 Co. USA John Dineen President and Chief Executive Officer GE Healthcare United Kingdom Laurie L. Dippenaar Chairman FirstRand Ltd South Africa

m Broadbent Andreas Brodtmann Managing Partner Joh. Berenberg, Gossler & Co. Germany KG Matthew Bromberg Vice-President, Corporate Strategy & United Technologies USA Development Corporation (UTC) Beth A. Brooke Global Vice-Chair. Public Policy Ernst & Young USA Stuart Brooks Special Adviser Chevron C